Filing Flows › HCW Biologics (HCWB) › Q2 2026 › vs Q2 2025
HCW Biologics (HCWB) Q2 2026 vs Q2 2025 (year over year)
HCW Biologics's revenue rose $129K (21×) from $7K in Q2 2025 to $136K in Q2 2026.
HCW Biologics, Q2 2026: revenue $136K (21× year over year), net loss $5.2M, operating cash flow −$4.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $136K | $7K | $129K | 21× |
| Net loss | $5.2M | $1.9M | $3.3M | +171% |
| Costs & expenses | $5.4M | $3.5M | $1.9M | +54% |
| Operating costs | $3.3M | $3.5M | −$169K | -5% |
| Interest & other, net | $2.1M | −$1.5M | $3.6M | — |
| Research & development | $1.2M | $1.2M | −$23K | -2% |
| General & admin | $1.9M | $2.1M | −$226K | -11% |
| Operating cash sources | $5.2M | $1.9M | $3.3M | +171% |
| Depreciation & amortization | $127K | $292K | −$165K | -56% |
| Share-based compensation | $1K | $278K | −$277K | -100% |
| Working capital & other | $1.1M | −$1.9M | $3.0M | — |
| Cash used in operations | $4.0M | $3.3M | $684K | +21% |
| Net loss absorbed | $5.2M | $1.9M | $3.3M | +171% |
Questions
How much did HCW Biologics's revenue grow year over year in Q2 2026?
HCW Biologics's revenue rose $129K (21×) from $7K in Q2 2025 to $136K in Q2 2026.